Abionyx Pharma annual net debt
2019
2020
2021
2022
2023
2024
2025
Abionyx Pharma Net Debt Growth & History (ABNX)
Abionyx Pharma's net debt was €284,000 for fiscal 2025.
View full Abionyx Pharma company overviewAbionyx Pharma annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €284,000 | €762,000 | — |
| 2024 | 2024-12-31 | −€478,000 | €236,000 | — |
| 2023 | 2023-12-31 | −€714,000 | −€681,000 | — |
| 2022 | 2022-12-31 | −€33,000 | €3.6M | — |
| 2021 | 2021-12-31 | −€3.6M | €5.5M | — |
| 2020 | 2020-12-31 | −€9.1M | −€882,000 | — |
| 2019 | 2019-12-31 | −€8.2M | — | — |
Abionyx Pharma quarterly net debt
Q4.24
Q4.25
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | €284,000 | €762,000 | — |
| Q4 2024 | 2024-12-31 | −€478,000 | — | — |
Abionyx Pharma net debt trends
Over the last five fiscal years, Abionyx Pharma's net debt increased from −€9.1M to €284,000, a change of €9.4M. The latest reported quarter, Q4 2025, shows €284,000.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abionyx Pharma source filings ↗